US Patent Issued to FNCT BIOTECH on Sept. 1 for "Use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,073, issued on Sept. 1, was assigned to FNCT BIOTECH INC (Seoul, South Korea).

"Use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis" was invented by Su Jae Lee (Seoul, South Korea), Mi Young Choi (Seoul, South Korea), Jae Kyung Myung (Seoul, South Korea), Min Jung Kim (Seoul, South Korea) and Hae June Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis and, more specifically, to: a marker for diagnosing the level of development or progression of pulmonary fibrosis, comprising M-CSF and/or G-CSF; and a compo...